SEC Form 4 · accession 0001209191-18-057941
IMMUNE DESIGN CORP. · IMDZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sergey Yurasov
Officer — Sr. VP, Clinic. Devel. & CMO
Period of report
Nov 7, 2018
Accepted (ET)
Nov 9, 2018 · 4:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001437786
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 7, 2018 | A | 29,953 | $0.00 | A | 57,278 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Immune Design Corp. common stock.
- F2Restricted stock units shall vest in a single installment on November 7, 2019, subject to the Reporting Person's continuous service through such date.